Clinical trial · Interventional
INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
NCT06246084CI-TRIAL-00084980completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research is being done to pilot an intervention which aims to improve participants' experiences on Endocrine Therapy. The name of the intervention used in this research study is: Endocrine Therapy Education Program (a brief, video-based intervention)
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Breast Cancer Female | Breast Neoplasm | PROBABILISTIC | 0.70 |
| Breast Carcinoma | Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endocrine Therapy Education Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group A: Endocrine Therapy Education Intervention
- description
- Participants will complete: * Baseline visit. * Educational video once a week for 6 weeks. * 6-week survey. * 3-month survey.
- interventionNames
- Behavioral: Endocrine Therapy Education Program
- type
- NO_INTERVENTION
- label
- Group B: Wait-List Control Group
- description
- Participants will complete: * Baseline visit. * 6-week survey. * 3-month survey. * Access to intervention educational videos. * 2-week post video survey.
Primary outcomes (3)
- measure
- Engagement Rate of Intervention
- timeFrame
- 6 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Biologically female * About to begin or just started (within four weeks of starting) an oral form of ET (either tamoxifen or AI) * 18 years of age or older * English fluency for reading and writing. * Computer literacy (ability to watch videos and fill out questionnaires online) Exclusion Criteria: * Adults unable to consent * Individuals with metastatic cancer * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners
References
Publications (0)
Data not yet available
No reference posted for this study.